logo-loader
AIM:GDR

Genedrive PLC

Market:
AIM
Market Cap:
£10.11 m
Price
29.00 GBX
Change
48.72%
52 weeks high
40.00
52 weeks low
6.25

In brief

Genedrive plc is a molecular diagnostics company developing and commercialising a low cost, rapid, versatile, simple to use and robust point of need molecular diagnostics platform for the diagnosis of infectious diseases and for use in patient stratification (genotyping), pathogen detection and other indications. We are passionate about the opportunity to not only build a sustainable business around molecular diagnostics, but to play an important role in the diagnostic and treatment challenges presented by Global Health issues.

Insight Widest with the analysis, Proactive gives perspectives that others don't.

Firms across the coronavirus treatment chain see share prices surge

Companies involved in diagnostics, drug development and medical equipment provision have all seen strong stock price rises as the world grapples with the pandemic

11 hours, 40 minutes ago